Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain

Overview of attention for article published in Clinical Drug Investigation, May 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 1 X post from an account with 889 followers.

Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice… https://t.co/NoYXjmlODf

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.